• Busca personas
• Intranet

Farmacología integrada y neurociencia de sistemas Rafael de la Torre

Publicaciones 2023 (15)

• Lorenzon N, Musoles J, Turrisi F, Gomis-González M, de la Torre R, Dierssen M^*. State-of-the-art therapy for Down syndrome. Dev Med Child Neurol 2023: (en Premsa).
• Sánchez-Larsen Á^*, Principe A, Ley M, Vaquerizo B, Langohr K, Rocamora R. Insular Role in Blood Pressure and Systemic Vascular Resistance Regulation. Neuromodulation 2023: (en Premsa).
• Sathyanarayanan A, Mueller TT, Ali-Moni M, Schueler K, Baune BT, Lio P, Mehta D^*, Baune BT, Dierssen M, Ebert B, Fabbri C, Fusar-Poli P, Gennarelli M, Harmer C, Howes OD, Janzing JGE, Lio P, Maron E, Mehta D, Minelli A, Nonell L, Pisanu C, Potier MC, Rybakowski F, Serretti A, Squassina A, Stacey D, van Westrhenen R, Xicota L, European College of Neuropsychopharmacology (ECNP) Pharmacogenomics & Transcriptomics Network. Multi-omics data integration methods and their applications in psychiatric disorders. Eur Neuropsychopharmacol 2023; 69: 26-46 (en Premsa).
  Cites:2
  Cites:2
• Bellaver B, Puig-Pijoan A, Ferrari-Souza JP, Leffa DT, Lussier FZ, Ferreira PCL, Tissot C, Povala G, Therrieault J, Benedet AL, Ashton NJ, Servaes S, Chamoun M, Stevenson J, Rahmouni N, Vermeiren M, Macedo AC, Fernández A, García-Escobar G, Navalpotro I, Lopez Ó, Tudorascu DL, Cohen A, Villemagne VL, Klunk WE, Gauthier S, Zimmer ER, Karikari TK, Blennow K, Zetterberg H, Suarez-Calvet M, Rosa-Neto P, Pascoal TA^*. Blood-brain barrier integrity impacts the use of plasma amyloid-β as a proxy of brain amyloid-β pathology. Alzheimers Dement 2023: (en Premsa).
• Delgado-Sallent C, Gener T, Nebot P, López-Cabezón C, Puig MV^*. Neural substrates of cognitive impairment in a NMDAR hypofunction mouse model of schizophrenia and partial rescue by risperidone. Front Cell Neurosci 2023; 17: 1152248 (Acceptat).
• Santos D^*, De Deus T, Cores C, Feal-Painceiras M, ÍñiguezAlvarado MC, Jesús S, Buongiorno MT, Planellas L, Cosgaya M, Garcia J, Caballol N, Legarda I, Hernández-Vara J, Cabo I, Lopez L, González-Aramburu I, Ávila MA, Gómez V, Nogueira V, Puente VM, Dotor-García-Soto J, Borrué C, Solano B, Alvarez-Sauco M, Vela L, Escalante S, Cubo E, Carrillo F, Martínez-Castrillo JC, Sanchez-Alonso P, Alonso Mg, Lopez-Ariztegui N, Gastón I, Kulisevsky J, Blazquez-Estrada M, Seijo M, Ruiz-Martínez J, Valero C, Kurtis M, De Fabregues O, Gonzalez-Ardura J, Alonso-Redondo R, Ordás C, López LM, McAfee D, Martínez-Martín P, Mir P, Study Group Coppadis . Prevalence and Factors Associated with Drooling in Parkinson's Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group. Parkinsons Dis 2023; 2023: 3104425 (Acceptat).
• García-Escobar G, Puig-Pijoan A, Puente VM, Fernández A, Manero RM, Navalpotro I, Suarez-Calvet M, Grau-Rivera O, Contador J, Cascales D, Duran X, Boltes N, Pont MCr, Ortiz-Gil J, Carrillo S, López-Villegas MD, Abellan-Vidal MT, Martínez-Casamitjana MI, Hernández-Sánchez JJ, Padrós A, Peña-Casanova J, Sánchez-Benavides G^*. NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-β and Tau Levels in the Continuum of Alzheimer's Disease. J Alzheimers Dis 2023; 92(4): 1303-1321.
• Melero JL, Lidon C^*, Pérez-Ortuño R, Fu M, Ballbè M, Martín-Sánchez JC, Gonzalez-Marron A, Cartanyà À, Pascual JA, Fernández E, Martínez-Sánchez JM. Specific biomarker comparison in current smokers, e-cigarette users, and non-smokers. Addict Behav 2023; 140: 107616.
• Fresán U^*, Bernard P, Fabregues S, Boronat A, Araújo-Soares V, König LM, Chevance G. A Smartphone Intervention to Promote a Sustainable Healthy Diet: Protocol for a Pilot Study. JMIR Res Protoc 2023; 12: e41443.
• Lantero J^*, Vrillon A, Fernández A, Ortiz-Romero P, Snellman A, Montoliu-Gaya L, Brum WS, Cognat E, Dumurgier J, Puig-Pijoan A, Navalpotro I, García-Escobar G, Karikari TK, Vanmechelen E, Ashton NJ, Zetterberg H, Suarez-Calvet M, Paquet C, Blennow K. Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts. Alzheimers Res. Ther. 2023; 15(1): 48.
• Santos D^*, De Deus T, Cores C, Feal-Painceiras M, ÍñiguezAlvarado MC, García-Díaz I, Jesús S, Buongiorno MT, Planellas L, Cosgaya M, Garcia J, Caballol N, Legarda I, Hernández-Vara J, Cabo I, Lopez L, González-Aramburu I, Ávila MA, Gómez V, Nogueira V, Puente VM, Dotor-García-Soto J, Borrué C, Solano B, Alvarez-Sauco M, Vela L, Escalante S, Cubo E, Carrillo F, Martínez-Castrillo JC, Sanchez-Alonso P, Alonso Mg, Lopez-Ariztegui N, Gastón I, Kulisevsky J, Menéndez M, Seijo M, Ruiz-Martínez J, Valero C, Kurtis M, Gonzalez-Ardura J, Alonso-Redondo R, Ordás C, López LM, McAfee D, Calopa M, Carrillo F, Escamilla-Sevilla F, Freire-Alvarez E, Gómez-Esteban JC, Garcia-Ramos R, Isabel-Luquín MR, Martínez-Torres I, Sesar A, Martínez-Martín P, Mir P, COPPADIS Study Group. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life. J Parkinsons Dis 2023; 13(3): 379-402.
• Pérez-Martín H, Lidon C^*, Gonzalez-Marron A^*, Fu M, Pérez-Ortuño R, Ballbè M, Martín-Sánchez JC, Pascual JA, Fernández E, Martínez-Sánchez JM. Variation in Nicotine Metabolization According to Biological Factors and Type of Nicotine Consumer. Healthcare (Basel) . 2023; 11(2): 179.
• Soldevila N, Lorenzo T, Forcano L, Cuenca A, Boronat A, Piera I, Minguillón C, Fauria K, Grau-Rivera O, Gispert JD, Molinuevo JL, de la Torre R. Living Labs. Brains 2023; 2(4): .
  Cites:0
• Barrera M, Veza E, Gomis-González M, Garcia-Quintana J, Trabsa A, Martinez-Sadurni L, Pujadas-Bastardes M, Pérez V, de la Torre R, Bergé D, Robledo P^*. Role of cyclin-dependent kinase 5 in psychosis and the modulatory effects of cannabinoids. Neurobiol Dis 2023; 176: 105942.
• Soldevila N, Pastor A, Sala-Vila A, Lázaro López I, Boronat A, Muñoz D, Castañer O, Fagundo AB, Corella D, Fernández-Aranda F, Martínez-González MA, Salas Salvadó J, Fitó Colomer M, de la Torre R^*. Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: Association with insulin resistance and weight loss in a population with metabolic syndrome. Front Nutr 2023; 9: 1076677 (Acceptat).